How much is Avidity Biosciences worth in 2026?

Avidity Biosciences has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Avidity Biosciences raised?

Avidity Biosciences has raised N/A in total funding across 1 funding rounds.

Avidity Biosciences

Drug Discovery

Avidity Biosciences valuation and funding history | Last updated: March 4, 2024 | 1 funding rounds

Current Valuation

N/A

As of March 4, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$400.2M

Last Funding

Mar 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 4, 2024	PIPE	$400.2M	N/A	-

Valuation Analysis

Current Valuation Metrics

Avidity Biosciences is currently valued at N/A as of March 4, 2024.

Track Avidity Biosciences Valuation Updates

Get notified when Avidity Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Avidity Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Avidity Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Avidity Biosciences Worth in 2026?

Avidity Biosciences is a leading private company in the Drug Discovery sector. Track Avidity Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Avidity Biosciences Valuation is Determined

Private company valuations like Avidity Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.